دورية أكاديمية
Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.
| العنوان: | Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting. |
|---|---|
| المؤلفون: | McBride A; University of Arizona Cancer Center, Tucson, AZ alimcbride@gmail.com., Campen CJ; Greenville Health System Cancer Institute, Greenville, SC., Camamo J; Banner-University Medical Center Tucson, Tucson, AZ., Maloney M; Banner-University Medical Center Tucson, Tucson, AZ., Persky D; University of Arizona Cancer Center, Tucson, AZ., Kurtin SE; Clinical Assistant Professor of Medicine Adjunct Clinical Assistant Professor of Nursing, University of Arizona Cancer Center, Tucson, Arizona., Barket NL; The University of Arizona Cancer Center, Tucson, AZ., Krishnadasan R; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ., Elquza E; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ., Anwer F; Department of Medicine, University of Arizona Cancer Center, Tucson, AZ., Weibel K; Banner-University Medical Center Tucson, Tucson, AZ. |
| المصدر: | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2018 May 01; Vol. 75 (9), pp. e246-e258. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN: 1535-2900 (Electronic) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2019-> : [Oxford] : Oxford University Press Original Publication: Bethesda, MD : The Society, c1995- |
| مواضيع طبية MeSH: | Ambulatory Care/*methods , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Pharmacists/*organization & administration , Pharmacy Service, Hospital/*organization & administration, Academic Medical Centers ; Ambulatory Care/economics ; Antineoplastic Combined Chemotherapy Protocols/economics ; Arizona ; Cost Savings ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/drug therapy ; Neoplasms/economics ; Neoplasms/pathology ; Patient Care Team/organization & administration ; Patient Transfer/organization & administration ; Rituximab/administration & dosage |
| مستخلص: | Purpose: Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting is described. Summary: The University of Arizona Cancer Center and Banner-University Medical Center Tucson are affiliated not-for-profit academic medical centers in Tucson, Arizona, whose facilities include a hospital and ambulatory care clinics that maintain 3 outpatient infusion centers. The cancer center pharmacy currently employs 25 pharmacists, with 4 clinical pharmacists serving both the inpatient and outpatient treatment sites. A multidisciplinary team of staff members was assembled to address the transition of chemotherapy from inpatient to outpatient that included physicians, ambulatory clinical oncology pharmacists, finance, social workers, pharmacy staff, nursing staff, and information technology. The program was initiated in May 2014, with a 2-year postimplementation evaluation of our transition of chemotherapy to the outpatient setting. Chemotherapy order sets were developed in our electronic medical record for transitioning rituximab to the outpatient setting for inpatient chemotherapy orders as well as transitioning leukemia, lymphoma, and solid tumor chemotherapy regimens to be administered in the outpatient setting. Eighteen rituximab-containing regimens and 14 chemotherapy protocols were switched to the outpatient setting, with numerous variants of these regimens also created for outpatient only administration. The realized savings for high-cost chemotherapy transitioned to the outpatient setting with rituximab and clofarabine was $1,902,890. Over 747 inpatient bed days were saved, with an approximated cost savings to the health system of $1,402,866, with a cumulative cost savings to our health system of $3,305,756. Conclusion: This model for transitioning chemotherapy from the hospital to the outpatient setting enhanced access to care, decreased bed utilization in the hospital, and improved clinical and financial metrics. (Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: EPOCH; ESHAP; HiDAC; ambulatory chemotherapy administration; clofarabine; outpatient chemotherapy |
| المشرفين على المادة: | 4F4X42SYQ6 (Rituximab) |
| تواريخ الأحداث: | Date Created: 20180426 Date Completed: 20190206 Latest Revision: 20190215 |
| رمز التحديث: | 20231215 |
| DOI: | 10.2146/ajhp170138 |
| PMID: | 29691269 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1535-2900 |
|---|---|
| DOI: | 10.2146/ajhp170138 |